Heart Rate Variability (HRV): How to Interpret Your Result

What HRV Actually Measures

HRV does not measure heart rate itself. It quantifies the variation in time between consecutive R-wave peaks on an ECG, the so-called RR intervals. A heart beating 60 times per minute does not fire exactly every 1,000 ms; a healthy heart oscillates between, say, 920 ms and 1,080 ms depending on breathing, blood pressure reflexes, and autonomic input. More variation generally means better autonomic flexibility.

The autonomic nervous system connection

The two branches of the autonomic nervous system pull in opposite directions. The parasympathetic branch, driven largely by the vagus nerve, slows the heart and increases interval variability. The sympathetic branch accelerates the heart and compresses variability. A high HRV score, therefore, is a proxy for strong vagal tone and a well-balanced autonomic system rather than purely a cardiac measurement. The 1996 Task Force standards define this framework and remain the clinical gold standard for HRV terminology. [1]

Time-domain vs. Frequency-domain metrics

Clinicians use two families of HRV metrics:

• RMSSD (root mean square of successive differences): the most common time-domain metric, sensitive to short-term parasympathetic activity. Consumer wearables almost universally report this.
• SDNN (standard deviation of all RR intervals): captures both sympathetic and parasympathetic variation over 24 hours. Used more often in clinical cardiology research.
• HF power and LF power (frequency-domain): separate parasympathetic (high-frequency, 0.15 to 0.40 Hz) from mixed sympathetic-parasympathetic (low-frequency, 0.04 to 0.15 Hz) contributions. Require clean ECG data and spectral analysis software.

For everyday health monitoring, RMSSD is the practical choice. Most of the figures in this article refer to RMSSD unless stated otherwise.

What Is a Normal HRV Range?

There is no single universal normal. Population studies reveal wide inter-individual variation, and a value that is low for a 25-year-old athlete may be entirely typical for a 65-year-old sedentary adult. [2]

Age-stratified reference values

A cross-sectional analysis of 1,919 adults published in Frontiers in Physiology found the following RMSSD medians by age group: [2]

| Age group | Median RMSSD (ms) | Typical range (10th, 90th percentile) | |-----------|-------------------|---------------------------------------| | 18 to 30 | 48 ms | 28 to 87 ms | | 31 to 45 | 38 ms | 20 to 72 ms | | 46 to 60 | 30 ms | 16 to 58 ms | | 61 to 75 | 23 ms | 12 to 44 ms |

These figures use 5-minute resting recordings. Overnight averages from wearables tend to run 10 to 20 ms higher because sleep promotes parasympathetic dominance.

Sex differences

Pre-menopausal women tend to show slightly higher RMSSD than age-matched men, an effect linked to estrogen's modulatory action on vagal tone. After menopause, this advantage largely disappears. One observational study of 478 participants showed that postmenopausal women had RMSSD values 8.4 ms lower on average than pre-menopausal women of similar fitness levels. [3]

Your personal baseline matters most

Chasing a population median is less useful than tracking your own 30-day rolling average. A single morning reading 15 to 20% below your personal baseline is a more actionable signal of incomplete recovery or acute stress than whether you score 35 ms versus 45 ms in absolute terms. This is the approach recommended by most sports medicine organizations for athlete monitoring.

What Does a Low HRV Mean?

A low HRV indicates that the autonomic nervous system is skewed toward sympathetic dominance. The heart fires with less interval variability. Short-term, this is normal during exercise or acute stress. Persistently low HRV at rest is a different matter.

Cardiovascular risk

The Framingham Heart Study found that the lowest quartile of SDNN was associated with a 3.5-fold increase in all-cause mortality compared with the highest quartile over a 20-year follow-up. [4] A separate meta-analysis of 21 prospective cohort studies (N = 46,000+) confirmed that reduced HRV independently predicts major adverse cardiac events (MACE) with a pooled hazard ratio of 1.45 (95% CI: 1.30 to 1.62). [5]

Metabolic and endocrine contributors

Several modifiable hormonal conditions suppress HRV:

• Type 2 diabetes and insulin resistance: Autonomic neuropathy is a recognized complication. The American Diabetes Association notes that cardiac autonomic neuropathy, detectable via HRV reduction, affects 20% of people with type 2 diabetes within 10 years of diagnosis. [6]
• Hypothyroidism: Thyroid hormone directly modulates cardiac ion channels and autonomic tone. Overt hypothyroidism reduces RMSSD; treatment with levothyroxine to a TSH of 0.5 to 2.5 mIU/L typically restores values toward baseline within 12 weeks.
• Low testosterone (hypogonadism): A prospective study of 312 men found that free testosterone correlated positively with RMSSD (r = 0.41, P<0.001), and TRT normalized HRV in hypogonadal men over 6 months. [7]
• Chronic sleep deprivation: Even one week of 6-hour sleep restriction reduced RMSSD by 17% in a controlled inpatient study of 24 healthy adults. [8]

Psychological and lifestyle contributors

Sustained psychological stress, heavy alcohol consumption, and overtraining syndrome each suppress parasympathetic output and lower HRV. An RMSSD persistently below 20 ms warrants a clinical review, not just lifestyle coaching.

What Does a High HRV Mean?

A high HRV, read correctly, is a favorable physiological signal. Strong parasympathetic tone supports faster post-exercise recovery, lower resting blood pressure, and better metabolic flexibility. [9]

Athletic adaptation

Aerobic training is the most reliable way to raise HRV. A 12-week randomized controlled trial of moderate-intensity continuous training (150 min/week) in previously sedentary adults raised RMSSD by a mean of 7.3 ms (P<0.001) versus a control group that showed no significant change. [10] Elite endurance athletes commonly post RMSSD values of 90 to 120 ms, reflecting years of cardiac vagal remodeling.

When very high HRV warrants caution

Extremely elevated HRV in symptomatic individuals can occasionally signal pathology rather than fitness:

• Third-degree (complete) heart block: The block dissociates atrial and ventricular rhythms, producing artificially high beat-to-beat variability in some calculation methods.
• Sick sinus syndrome: Irregular sinus pauses inflate RMSSD if the recording algorithm does not filter ectopic beats.
• Parasympathetic excess in vasovagal syncope: Some patients with frequent fainting episodes show paradoxically high resting HRV with impaired baroreflex buffering.

In the absence of symptoms such as dizziness, syncope, or palpitations, a high RMSSD in a healthy individual requires no intervention.

How to Improve a Low HRV

The following framework organizes the evidence-based interventions by mechanism and time to effect. Clinicians at HealthRX use this tiered approach when evaluating patients with chronic HRV suppression:

Tier 1: High-evidence lifestyle modifications (effect in 4 to 12 weeks)

Aerobic exercise. The strongest single intervention. The 2023 AHA Physical Activity Guidelines state that 150 minutes per week of moderate-intensity aerobic activity produces measurable autonomic benefits within 8 weeks. [11] Zone 2 training (roughly 60 to 70% of maximum heart rate) appears to drive the largest HRV gains by preferentially conditioning vagal pathways without excessive sympathetic loading.

Sleep quality. Targeting 7 to 9 hours per night with consistent sleep and wake times restores parasympathetic dominance during slow-wave sleep. In the previously mentioned inpatient study, re-extending sleep to 8 hours for 3 recovery nights raised RMSSD back to 97% of baseline. [8]

Alcohol reduction. Even moderate alcohol intake (2 standard drinks per night) acutely suppresses RMSSD by approximately 22% the following morning. Removing alcohol is often the fastest single lifestyle change for raising morning HRV in regular drinkers.

Tier 2: Breathing and nervous system techniques (effect in 2 to 8 weeks)

Resonance frequency breathing. Slow breathing at approximately 5 to 6 breaths per minute amplifies heart rate oscillations and has been shown in RCTs to raise RMSSD and baroreflex sensitivity. A meta-analysis of 14 trials found a pooled improvement of 9.0 ms RMSSD with 8 weeks of daily 20-minute sessions. [12]

Cold water exposure. Brief cold-water immersion (15°C, 3 minutes, 3 times per week for 6 weeks) raised RMSSD by 5.4 ms in a small RCT of 40 healthy adults. The mechanism likely involves vagal activation through the diving reflex. [13]

Tier 3: Medical management of underlying causes (effect in 6 to 24 weeks)

When HRV suppression stems from an identifiable medical condition, treating the root cause produces the largest and most durable gains:

• Optimizing thyroid replacement (levothyroxine titrated to TSH 0.5 to 2.5 mIU/L)
• Initiating TRT in hypogonadal men (testosterone cypionate 100 to 200 mg/week or equivalent)
• Glycemic optimization in type 2 diabetes (HbA1c reduction below 7.0% partially reverses autonomic neuropathy according to the DCCT/EDIC trial) [6]
• Treating obstructive sleep apnea with CPAP (AHI <5 events/hour), which raised RMSSD by 8.7 ms in a 6-month observational study of 88 patients

How HRV Is Measured Clinically vs. With Wearables

Clinical HRV measurement uses a 12-lead or Holter ECG with software that identifies R-wave peaks to the millisecond. A standard 5-minute resting ECG is sufficient for RMSSD; a 24-hour Holter provides SDNN and frequency-domain metrics.

Consumer wearable accuracy

Chest strap monitors (Polar H10, Garmin HRM-Pro) show excellent agreement with ECG, with Pearson r values of 0.90 to 0.95 for RMSSD in published validation studies. [14] Wrist-based optical photoplethysmography (PPG) sensors, found in Apple Watch, Fitbit, and Garmin wrist devices, are less accurate, particularly during movement. At rest, however, newer PPG algorithms in Apple Watch Series 9 demonstrated r = 0.87 vs. ECG in a 2024 validation study of 55 subjects. [15]

Standardizing your readings

To make day-to-day comparisons meaningful:

• Measure at the same time each morning, immediately after waking, before caffeine
• Lie supine for at least 60 seconds before starting a 5-minute recording
• Avoid readings within 12 hours of significant alcohol, within 2 hours of intense exercise, or during acute illness
• Use a 30-day rolling average rather than single-day values for trend analysis

A reading taken under inconsistent conditions can shift apparent RMSSD by 20 to 30 ms, dwarfing the biological signal you are trying to track.

HRV in the Context of Hormonal and Metabolic Health

For patients seeking care at a hormone therapy or metabolic health clinic, HRV provides an objective, non-invasive window into treatment response. Changes in RMSSD over 8 to 12 weeks of therapy can confirm that a hormonal intervention is producing the intended autonomic benefit beyond what blood panels alone reveal.

Testosterone and HRV

Both deficiency and supraphysiologic excess of testosterone affect autonomic tone. Hypogonadal men show suppressed parasympathetic activity that partly normalizes with TRT. The prospective study cited above [7] found that men achieving free testosterone in the 100 to 150 pg/mL range after 6 months of TRT gained a mean of 11 ms RMSSD, while men who over-corrected above 200 pg/mL showed a smaller 4 ms improvement, consistent with the inverted-U relationship between androgen signaling and vagal tone.

Estrogen, menopause, and HRV

The menopause transition is associated with a measurable HRV decline independent of aging. The Women's Health Initiative found that women who initiated hormone therapy within 10 years of menopause had significantly better autonomic indices at 3-year follow-up than age-matched controls. [16] This does not establish causality, but it supports using HRV as one monitoring endpoint when managing menopausal hormone therapy.

GLP-1 receptor agonists and HRV

Semaglutide and other GLP-1 receptor agonists reduce sympathetic overactivity associated with obesity and insulin resistance. In STEP-1 (N = 1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks vs. 2.4% placebo. [17] Weight loss of that magnitude is independently associated with 10 to 15 ms RMSSD improvement, based on bariatric surgery cohort data, suggesting GLP-1 therapy may raise HRV as a secondary benefit of fat mass reduction and improved insulin sensitivity.

Red Flags: When to Seek Urgent Evaluation

Most HRV readings are informational rather than urgent. Seek same-day or emergency evaluation if a low HRV reading accompanies any of the following:

• Chest pain, pressure, or radiation to the jaw or left arm
• Sustained resting heart rate above 130 bpm or below 40 bpm
• New syncope or near-syncope
• Significant palpitations lasting more than 30 minutes
• Wearable alert for atrial fibrillation confirmed on a rhythm strip

The American Heart Association's 2019 scientific statement on wearable device monitoring notes that device-detected arrhythmias require confirmatory 12-lead ECG or 48-hour Holter before clinical decisions are made. [18]

Putting It Together: A Practical Interpretation Guide

Reading your HRV result in isolation is rarely enough. The most clinically useful approach combines three data points:

1. Your current reading compared with your personal 30-day average
2. Trend direction over the past 4 to 8 weeks (rising, stable, or falling)
3. Contextual factors the night before (sleep duration, alcohol, training load, illness)

A single low reading after a poor night of sleep is noise. A reading that sits 25% below your 30-day average for 10 consecutive days, without an obvious acute cause, deserves a clinical conversation, particularly if accompanied by fatigue, reduced exercise tolerance, or changes in resting heart rate.

Patients using HealthRX's lab monitoring program should share their 30-day HRV trend data alongside standard blood panels so their provider can assess autonomic health in the context of hormonal and metabolic findings. Providers interpreting RMSSD below 20 ms in conjunction with low free testosterone, elevated fasting insulin, or poorly controlled thyroid function should prioritize addressing the underlying hormonal cause before adding standalone HRV interventions.